Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Mitochondrial complex II orchestrates divergent effects in CD4+ and CD8+ T cells
Keisuke Seike, Shih-Chun A. Chu, Yuichi Sumii, Takashi Ikeda, Meng-Chih Wu, Laure Maneix, Dongchang Zhao, Yaping Sun, Marcin Cieslik, Pavan Reddy
Keisuke Seike, Shih-Chun A. Chu, Yuichi Sumii, Takashi Ikeda, Meng-Chih Wu, Laure Maneix, Dongchang Zhao, Yaping Sun, Marcin Cieslik, Pavan Reddy
View: Text | PDF
Research Article Hematology Immunology Metabolism

Mitochondrial complex II orchestrates divergent effects in CD4+ and CD8+ T cells

  • Text
  • PDF
Abstract

Mitochondrial metabolism orchestrates T cell functions, yet the role of specific mitochondrial components in distinct T cell subsets remains poorly understood. Here, we explored the role of mitochondrial complex II (MC II), the only complex from the electron transport chain (ETC) that plays a role in both ETC and metabolism, in regulating T cell functions. Surprisingly, MC II exerts divergent effects on CD4+ and CD8+ T cell activation and function. Using T cell–specific MC II subunit, succinate dehydrogenase A–deficient (SDHA-deficient) mice, we integrated single-cell RNA-seq and metabolic profiling, with in vitro and in vivo T cell functional assays to illuminate these differences. SDHA deficiency induced metabolic changes and remodeled gene expression exclusively in activated T cells. In CD4+ T cells, SDHA loss dampened both oxidative phosphorylation (OXPHOS) and glycolysis, impaired cytokine production, proliferation, and reduced CD4+ T cell–mediated graft-versus-host disease after allogeneic stem cell transplantation (SCT). In contrast, SDHA deficiency in CD8+ T cells reduced OXPHOS but paradoxically upregulated glycolysis and demonstrated enhanced cytotoxic functions in vitro and in vivo. This metabolic reprogramming endowed SDHA-KO CD8+ T cells with superior in vivo antitumor efficacy after immune checkpoint inhibitor therapy and allogeneic SCT. These findings reveal MC II as a bifurcation point for metabolic and functional specialization in CD4+ and CD8+ T cells.

Authors

Keisuke Seike, Shih-Chun A. Chu, Yuichi Sumii, Takashi Ikeda, Meng-Chih Wu, Laure Maneix, Dongchang Zhao, Yaping Sun, Marcin Cieslik, Pavan Reddy

×

Figure 1

SDHA is required for T cell proliferation and survival following stimulation in vitro.

Options: View larger image (or click on image) Download as PowerPoint
SDHA is required for T cell proliferation and survival following stimula...
(A) Sdhafl/fl CD4-Cre (SDHA-KO) mice were generated using Sdha-floxed mice and CD4-Cre mice. The FRT-flanked region in Sdha-floxed mice was excised and crossed with CD4-Cre mice to create Sdhafl/fl CD4-Cre mice. (B) Representative Western blot images of mitochondrial complexes in naive WT and naive SDHA-KO T cells. (C) Representative flow cytometry images of isolated splenic CD4+ and CD8+ T cells, expression of Sdha mRNA in CD4+ and CD8+ T cells from Sdhafl/fl CD4-Cre+ relative to Sdhafl/fl CD4-Cre– mice, and protein density quantification of SDHA in splenic CD4+ and CD8+ T cells from Sdhafl/fl CD4-Cre– and Sdhafl/fl CD4-Cre+ mice (n = 3/group). (D) The ratio of thymus cell subsets in naive WT and SDHA-KO mouse thymi (n = 4/group). (E) Representative flow cytometry images of sorted double-positive thymocytes and expression of Sdha mRNA in the double-positive cells from Sdhafl/fl CD4-Cre+ relative to Sdhafl/fl CD4-Cre– mice (n = 3/group). (F) The ratio of peripheral T cell subsets in naive WT and naive SDHA-KO splenic T cells (n = 5/group). (G) Succinate levels in WT and SDHA-KO T cells unstimulated and stimulated with CD3/CD28 antibodies for 48 hours or naive WT and SDHA-KO T cells (n = 9/group). (H and I) Proliferative capacity (H) and dead cells (I) of WT and SDHA-KO T cells, as measured by CFSE staining and 7-AAD+ Annexin V+ cells after CD3/CD28 antibody stimulation for 48 hours in vitro (n = 3-5/group). (J) Oxygen consumption rate (OCR, indicator of OXPHOS) in WT and SDHA-KO T cells stimulated by CD3/CD28 antibodies for 2 days, as measured by Seahorse analyzer (n = 6–8/group). Two-tailed unpaired t test (C–J) was used to determine significance (mean ± SEM). *P < 0.05, **P < 0.01, ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts